Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$1.06 - $1.97 $862,324 - $1.6 Million
813,514 Added 87.6%
1,742,190 $1.93 Million
Q4 2022

Feb 14, 2023

SELL
$1.4 - $25.4 $165,982 - $3.01 Million
-118,559 Reduced 11.32%
928,676 $1.36 Million
Q3 2022

Nov 14, 2022

SELL
$0.36 - $36.0 $1,696 - $169,668
-4,713 Reduced 0.45%
1,047,235 $1.92 Million
Q2 2022

Aug 15, 2022

BUY
$12.3 - $27.3 $2.46 Million - $5.46 Million
199,817 Added 23.45%
1,051,948 $1.45 Million
Q1 2022

May 16, 2022

SELL
$16.6 - $32.3 $3.01 Million - $5.86 Million
-181,576 Reduced 17.57%
852,131 $1.94 Million
Q4 2021

Feb 14, 2022

SELL
$29.9 - $61.2 $35.9 Million - $73.4 Million
-1,199,440 Reduced 53.71%
1,033,707 $3.09 Million
Q3 2021

Nov 12, 2021

SELL
$51.4 - $68.2 $40.6 Million - $53.9 Million
-790,633 Reduced 26.15%
2,233,147 $12.3 Million
Q2 2021

Aug 16, 2021

BUY
$44.1 - $84.0 $133 Million - $254 Million
3,023,780 New
3,023,780 $22.2 Million

Others Institutions Holding BNGO

About Bionano Genomics, Inc.


  • Ticker BNGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 290,140,000
  • Market Cap $58M
  • Description
  • Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...
More about BNGO
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.